Profile data is unavailable for this security.
About the company
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
- Revenue in EUR (TTM)635.20m
- Net income in EUR-24.50m
- Incorporated2006
- Employees2.50k
- LocationBiotest AGLandsteinerstr. 5DREIEICH 63303GermanyDEU
- Phone+49 61038010
- Fax+49 6 103801150
- Websitehttps://www.biotest.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chengdu Olymvax Biopharmaceuticals Inc | 86.48m | 7.83m | 1.34bn | 470.00 | 170.94 | 11.47 | -- | 15.52 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Shanghai Yizhong Pharmaceutical Co Ltd | 30.13m | 2.80m | 1.34bn | 65.00 | 471.02 | 7.54 | -- | 44.60 | 0.1132 | 0.1132 | 1.22 | 7.07 | 0.163 | 0.9556 | 2.26 | 3,800,801.00 | 1.51 | 5.44 | 1.58 | 5.64 | 81.39 | 92.99 | 9.30 | 36.90 | 7.84 | -- | 0.00 | 32.30 | -51.83 | -- | -95.68 | -- | 10.96 | -- |
| Jubilant Pharmova Ltd | 736.77m | 40.26m | 1.35bn | 978.00 | 33.53 | -- | 17.04 | 1.83 | 27.23 | 27.23 | 498.28 | -- | -- | -- | -- | 80,965,230.00 | -- | 3.37 | -- | 4.02 | 67.71 | 64.54 | 5.42 | 5.64 | -- | 4.06 | -- | 21.60 | 7.93 | 3.90 | 988.72 | 6.73 | 14.21 | 0.00 |
| Biotest AG | 635.20m | -24.50m | 1.36bn | 2.50k | -- | 2.86 | -- | 2.14 | -0.6505 | -0.6505 | 16.37 | 12.88 | 0.4437 | 1.01 | 2.88 | 254,589.20 | -1.72 | 0.4411 | -2.13 | 0.5137 | 23.19 | 28.69 | -3.87 | 0.9225 | 1.66 | 0.268 | 0.5675 | 13.41 | 6.08 | 11.62 | -79.21 | -- | -3.39 | -- |
| Veradermics Inc | 0.00 | -45.34m | 1.37bn | 19.00 | -- | -- | -- | -- | -1.53 | -1.53 | 0.00 | 0.3731 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -60.63 | -- | -- | -- |
| Cansino Biologics Inc | 118.52m | -17.32m | 1.37bn | 1.11k | -- | 2.99 | -- | 11.55 | -0.5455 | -0.5455 | 3.92 | 21.37 | 0.1271 | 0.5861 | 1.38 | 879,482.50 | -1.86 | -4.08 | -2.29 | -5.38 | 78.80 | 45.31 | -14.62 | -27.51 | 3.29 | -- | 0.2242 | -- | 137.01 | 226.43 | 74.45 | -- | 31.38 | -- |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 802.21m | 83.91m | 1.37bn | 8.26k | 16.62 | 1.58 | -- | 1.71 | 0.2665 | 0.2665 | 2.54 | 2.80 | 0.6617 | 2.57 | 4.70 | 796,529.00 | 7.13 | 8.51 | 9.65 | 12.74 | 51.88 | 58.64 | 10.77 | 14.12 | 1.38 | -- | 0.0532 | 41.54 | -3.23 | -0.7594 | 5.21 | -- | 1.57 | -- |
| Natco Pharma Ltd | 424.30m | 144.89m | 1.37bn | 4.20k | 9.48 | -- | 8.20 | 3.24 | 86.94 | 86.94 | 254.62 | -- | -- | -- | -- | 10,860,210.00 | -- | 15.82 | -- | 18.14 | 82.79 | 75.22 | 33.87 | 30.39 | -- | 44.51 | -- | 12.09 | 10.77 | 18.26 | 35.81 | 32.55 | 7.37 | -2.33 |
| Immunocore Holdings PLC - ADR | 319.83m | -24.62m | 1.37bn | 493.00 | -- | -- | -- | 4.30 | -0.5866 | -0.5866 | 7.49 | -- | 0.3471 | 0.5336 | 5.44 | 769,959.40 | -2.67 | -17.90 | -3.34 | -23.26 | 99.29 | -- | -7.70 | -53.74 | 5.97 | -- | 0.4975 | -- | 24.37 | 56.77 | 7.60 | -- | -1.06 | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -10.78bn | -10.78bn | 1.38bn | 105.00 | -- | 15.00 | -- | -- | -- | -- | -- | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
| Vimian Group AB | 424.15m | 31.13m | 1.38bn | 1.20k | 44.40 | 1.98 | 19.69 | 3.26 | 0.6265 | 0.6265 | 8.54 | 14.02 | 0.383 | 1.67 | 7.56 | -- | 2.92 | 1.42 | 3.27 | 1.62 | 68.90 | 69.18 | 7.62 | 3.96 | 1.22 | 7.96 | 0.2519 | 0.00 | 13.42 | 42.94 | 74.59 | -9.36 | 21.97 | -- |
| Pharma Mar SA | 179.28m | 34.01m | 1.38bn | 500.00 | 39.73 | 6.83 | 32.85 | 7.71 | 1.93 | 1.93 | 10.21 | 11.24 | 0.5314 | 0.1946 | 5.34 | 358,552.00 | 10.08 | 18.37 | 13.70 | 25.03 | 94.53 | 94.02 | 18.97 | 29.81 | 2.14 | -- | 0.2031 | -- | 10.56 | 15.30 | 2,197.71 | -- | 31.72 | -- |
| Chengdu Easton Biopharmaceuticals Co Ltd | 162.08m | 29.44m | 1.39bn | 1.52k | 46.91 | 3.97 | -- | 8.55 | 1.37 | 1.37 | 7.55 | 16.23 | 0.3809 | 1.83 | 5.89 | 873,161.50 | 6.92 | 8.09 | 8.44 | 9.82 | 71.90 | 81.72 | 18.16 | 20.10 | 3.12 | -- | 0.0444 | 30.37 | 20.82 | 7.34 | 5.15 | 17.01 | 4.24 | -- |
Data as of Feb 16 2026. Currency figures normalised to Biotest AG's reporting currency: Euro EUR
0.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Arvernus Capital AGas of 30 Sep 2025 | 13.23k | 0.07% |
| BANTLEON Invest GmbHas of 30 Nov 2023 | 2.00k | 0.01% |
| Ersel Asset Management SGR SpAas of 30 Jun 2025 | 0.00 | 0.00% |
Data from 29 Aug 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
